1,2-dipalmitoylphosphatidylcholine has been researched along with Disease Models, Animal in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Qi, J; Shen, Q; Shu, G; Ying, X; Zhang, X | 1 |
| Arieli, R; Khatib, S; Vaya, J | 1 |
| Chen, SC; Fan, NC; Ho, JA; Lee, CC; Lee, MT; Wang, HM; Yang, YL | 1 |
| Bao, S; Barter, PJ; Bursill, C; Di Bartolo, BA; Heather, AK; Nicholls, SJ; Rye, KA | 1 |
| Bates, SR; Dodia, C; Fisher, AB; Hawgood, S; Jain, D; Poulain, FR | 1 |
| Huang, W; Lewis, JF; McCaig, LA; Veldhuizen, RA; Yao, LJ | 1 |
| Di Giacomo, C; Fresta, M; Puglisi, G; Russo, A | 1 |
| Böck, P; Lohninger, AF; Lohninger, AK; Salzer, H; Sevelda, P | 1 |
| Cheng, G; Jori, G; Kenney, ME; Polo, L; Reddi, E; Rodgers, MA; Soncin, M | 1 |
| Cope, AS; Hagaman, KA; Krstenansky, JL; Lewis, JE; Matthews, ER; McLean, LR; Olsen, KF; Owen, TJ; Payne, MH; Uhrhammer, DC | 1 |
| Dial, EJ; Illich, PA; Lichtenberger, LM; Romero, JJ; Ulloa, C; Vanous, AL; Walters, ET | 1 |
| Alberts, MS; Anderson, DW; Cochrane, CG; Heldt, GP; Kheiter, A; Merritt, TA; Revak, SD | 1 |
| Higaki, H; Iwamoto, Y; Mawatari, T; Miura, H; Murakami, T; Nakanishi, Y | 1 |
| Ito, M; Otake, K; Saito, Y; Suwabe, A; Suzuki, H; Takahashi, K; Tomoike, H; Yakuwa, N | 1 |
| Coalson, JJ; Ikegami, M; Jobe, AH; Seidner, SR | 1 |
| Ikegami, M; Jobe, AH | 1 |
| Kobayashi, T; Matsumoto, Y; Nishizuka, K; Ohta, K; Suzuki, Y; Tashiro, K | 1 |
| Curstedt, T; Grossmann, G; Kobayashi, T; Kokubo, M; Robertson, B; Suzuki, Y | 1 |
18 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Disease Models, Animal
| Article | Year |
|---|---|
Sinomenine hydrochloride loaded thermosensitive liposomes combined with microwave hyperthermia for the treatment of rheumatoid arthritis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Cholesterol; Combined Modality Therapy; Cytokines; Disease Models, Animal; Drug Compounding; Drug Liberation; Female; Human Umbilical Vein Endothelial Cells; Humans; Hyperthermia, Induced; Joints; Lipids; Liposomes; Microwaves; Morphinans; Particle Size; Rats, Wistar; Solubility | 2020 |
Ovine plasma dipalmitoylphosphatidylcholine does not predict decompression bubbling.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Blood Vessels; Decompression; Decompression Sickness; Disease Models, Animal; Hydrophobic and Hydrophilic Interactions; Phenylenediamines; Sheep; Time Factors | 2019 |
Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cholesterol; Disease Models, Animal; Fluid Therapy; Interleukin-6; Isotonic Solutions; Light; Liposomes; Male; Phosphatidylethanolamines; Pulmonary Edema; Rats; Rats, Wistar; Resuscitation; Ringer's Lactate; Scattering, Radiation; Shock, Hemorrhagic; Tumor Necrosis Factor-alpha; Vasopressins | 2015 |
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Carotid Artery Diseases; Chemokine CCL2; Chemokine CX3CL1; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inflammation; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Lipoproteins; Lipoproteins, HDL; Molecular Mimicry; Monocytes; Peptides; Rabbits; RNA, Messenger; Signal Transduction; Sphingomyelins; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2011 |
SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Disease Models, Animal; Endocytosis; Hyperventilation; Lysosomes; Mice; Mice, Knockout; Phospholipases A; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein A; Stem Cells; Tritium | 2003 |
Mechanisms responsible for surfactant changes in sepsis-induced lung injury.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Analysis of Variance; Animals; Disease Models, Animal; Lipid Metabolism; Lung Diseases; Macrophages; Male; Probability; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Risk Factors; Sensitivity and Specificity; Sepsis | 2005 |
Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Blood-Brain Barrier; Brain Ischemia; Cerebral Cortex; Cholesterol; Chromatography, High Pressure Liquid; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Evaluation; Lactates; Lactic Acid; Lipid Peroxidation; Liposomes; Male; Phosphatidylserines; Rats; Rats, Wistar; Reperfusion Injury; Survival Rate | 1994 |
Antenatal betamethasone-dose-effects on fetal rat lung morphology and surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Betamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetal Organ Maturity; Fetus; Lung; Male; Phospholipids; Pregnancy; Pulmonary Surfactants; Rabbits; Rats; Rats, Wistar; Sex Factors | 1994 |
Effect of the delivery system on the biodistribution of Ge(IV) octabutoxy-phthalocyanines in tumour-bearing mice.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Disease Models, Animal; Drug Carriers; Emulsions; Female; Glycerol; Indoles; Liposomes; Liver; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Organometallic Compounds; Photosensitizing Agents; Spleen; Tissue Distribution | 1995 |
An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Disease Models, Animal; Drug Combinations; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; In Vitro Techniques; Lung Compliance; Male; Oligopeptides; Phosphatidylcholines; Pulmonary Gas Exchange; Pulmonary Surfactants; Rats; Respiratory Insufficiency; Structure-Activity Relationship; Therapeutic Irrigation | 1993 |
Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Analysis of Variance; Animals; Aspirin; Body Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Male; Pain; Rats; Rats, Sprague-Dawley | 1996 |
Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Amino Acid Sequence; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Lung; Macaca mulatta; Molecular Sequence Data; Peptides; Phosphatidylglycerols; Pregnancy; Pulmonary Surfactants; Radiography; Respiratory Distress Syndrome, Newborn | 1996 |
The lubricating ability of biomembrane models with dipalmitoyl phosphatidylcholine and gamma-globulin.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Friction; gamma-Globulins; Hyaluronic Acid; Injections, Intra-Articular; Lubrication; Osteoarthritis; Swine; Viscosity | 1998 |
Artificial surfactant (Surfactant TA) modulates adherence and superoxide production of neutrophils.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Apoptosis; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Adhesion; Cell Nucleus; Cells, Cultured; Cricetinae; Disease Models, Animal; Endopeptidases; fas Receptor; Humans; Leukocyte Count; Liposomes; Lung; Neutrophil Activation; Neutrophils; Pneumonia; Pulmonary Alveoli; Pulmonary Surfactants; Reactive Oxygen Species; Respiratory Distress Syndrome; Superoxides | 1998 |
Abnormal surfactant metabolism and function in preterm ventilated baboons.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Betamethasone; Bronchoalveolar Lavage Fluid; Carbon Radioisotopes; Disease Models, Animal; Female; Fetus; Gestational Age; Glucocorticoids; Lung; Maternal-Fetal Exchange; Palmitic Acid; Papio; Placebos; Pregnancy; Pulmonary Alveoli; Pulmonary Surfactants; Rabbits; Radiopharmaceuticals; Random Allocation; Respiration, Artificial; Surface Tension; Tritium | 1998 |
Surfactant protein-C in ventilated premature lamb lung.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Disease Models, Animal; Humans; Infant, Newborn; Lung; Proteolipids; Pulmonary Alveoli; Pulmonary Surfactants; Recombinant Proteins; Respiratory Distress Syndrome, Newborn; Sheep | 1998 |
Modified natural and synthetically reconstituted surfactant therapies for acute lung injury caused by endotoxin in rats.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Disease Models, Animal; Endotoxins; Escherichia coli; Follow-Up Studies; Male; Oxygen; Partial Pressure; Phosphatidylcholines; Phosphatidylglycerols; Positive-Pressure Respiration; Proteolipids; Pulmonary Surfactants; Random Allocation; Rats; Rats, Wistar; Respiratory Distress Syndrome | 1999 |
Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Apoproteins; Disease Models, Animal; Humans; Infant, Newborn; Lung; Lung Compliance; Phosphatidylglycerols; Pulmonary Alveoli; Pulmonary Surfactants; Rabbits; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Surface-Active Agents | 1988 |